Facial nerve dysfunction after parotidectomy: The role of local factors

Laryngoscope

Volumn 115, Issue 2, 2005, Pages 287-291

  Gaillard, Christophe ^a   Périé, Sophie ^a   Susini, Bertrand ^a   St Guily, Jean Lacau ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Facial nerve; Facial paralysis; Parotidectomy

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSECTION; FACIAL NERVE DISEASE; FACIAL NERVE PARALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANDIBULAR NERVE; MEDICAL RECORD; NERVE FUNCTION; NEUROFIBROMA; PAROTID GLAND CANCER; PAROTID GLAND TUMOR; PAROTIDECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEX; STUDENT T TEST; SURGEON; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ADENOLYMPHOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; FACIAL NERVE; FACIAL NERVE INJURIES; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PAROTID GLAND; PAROTID NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 13444292324     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000154735.61775.cd     Document Type: Review

References (14)

1. Rea JL. Partial parotidectomies: morbidity and benign tumor recurrence rates in a series of 94 cases. Laryngoscope 2000; 110:924-927.
2. Witt RL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002;112:2141-2154.
3. Bron LP, O'Brien CJ. Facial nerve function after parotidectomy. Arch Otolaryngol Head Neck Surg 1997;123:1091-1096.
4. Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Menard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-1494.
5. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head Neck Society and the American Academy of Otolaryngology - Head Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-758.
6. Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO international histological classification of tumours: tentative of histological classification of salivary gland tumours. Pathol Res Pract 1990;186:555-581.
7. Dulguerov P, Marchal F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope 1999; 109:754-762.
8. O'Brien CJ, Malka VB, Mijailovic M. Evaluation of 242 consecutive parotidectomies performed for benign and malignant disease. Aust N Z J Surg 1993;63:870-877.
9. Mehle ME, Kraus DH, Wood BG, et al. Facial nerve morbidity following parotid surgery for benign disease: the Cleveland Clinic Foundation experience. Laryngoscope 1993;103:386-388.
10. Terrell JE, Kileny PR, Yian C, et al. Clinical outcome of continuous facial nerve monitoring during primary parotidectomy. Arch Otolaryngol Head Neck Surg 1997;123:1081-1087.
11. Ward CM. Injury of the facial nerve during surgery of the parotid gland. Br J Surg 1975;62:401-403.
12. Patey DH, Moffat W. A clinical and experimental study of functional paralysis of the facial nerve following conservative parotidectomy. Br J Surg 1961;48:435-442.
13. Mra Z, Komisar A, Blaugrund SM. Functional facial nerve weakness after surgery for benign parotid tumors: a multivariate statistical analysis. Head Neck 1993;15:147-152.
14. Ellingson TW, Cohen JI, Andersen P. The impact of malignant disease on facial nerve function after parotidectomy. Laryngoscope 2003;113:1299-1303.